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Abstract  20 
Purpose: To investigate the extent to which inflammatory markers explain the association 21 
between handgrip strength and mortality.  22 
Methods: Analyses of data from The English Longitudinal Study of Ageing. Handgrip 23 
strength and inflammatory marker data (C-reactive protein and Fibrinogen) were collected at 24 
baseline (2004/5) and inflammatory marker data at follow up (2012/13). Participant data were 25 
linked with death records. General linear models were used to explore associations between 26 
handgrip strength and inflammatory markers at follow up. Cox proportional hazards 27 
regression models were used to examine associations between grip strength and risk of death. 28 
Models were estimated with the covariates age, sex, wealth, physical activity, smoking, 29 
depressive symptoms, long standing illness, adiposity.  30 
Results: The sample comprised 5,240 participants (mean age 65.9 (SD 9.4) yrs; 53.8% 31 
female). Over an average 9.7 ±1.4yrs follow up there were 650 deaths. Inverse associations 32 
were evident between handgrip strength and change in inflammatory markers in women only. 33 
There was an association between grip strength and lower risk of mortality in women (hazard 34 
ratio = 0.85; 95% CI, 0.74, 0.98) after adjusting for age and wealth. The association was 35 
attenuated after adjustment for clinical and behavioural risk factors (0.92; 0.79, 1.07), and 36 
further attenuated after adjusting for inflammatory markers (0.95; 0.82, 1.11). 37 
Conclusion: Higher grip strength is associated with lower levels of inflammation at 8-year 38 
follow-up, and inflammatory markers partly explained the association between handgrip 39 
strength and mortality. 40 
Keywords: Handgrip strength, mortality, inflammatory markers, ELSA  41 
 42 
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INTRODUCTION 43 
Physical activity promotes cardiorespiratory fitness and the maintenance of lean muscle mass 44 
with ageing.1 The health benefits of cardiorespiratory fitness are well established2  although 45 
less is known about muscle strength.3,4  46 
Handgrip strength is a valid measure of physical function/ performance that has been widely 47 
used in observational cohort studies and clinical settings.5-8 Several studies have shown that 48 
handgrip strength is inversely associated with risk of mortality9-11 although the mechanisms 49 
linking muscle strength and disease outcomes is poorly understood. One possible explanation 50 
is systemic inflammation. Systemic inflammation has been shown to be associated with a 51 
plethora of noncommunicable diseases (e.g. see, Ridker et al12 and Sin et al13).  52 
Three well studied inflammatory biomarkers include Interleukin 6 (IL-6), C-reactive protein 53 
(CRP), and Fibrinogen. Briefly, IL-6 is a pleiotropic cytokine that is secreted by T cells and 54 
macrophages to activate immune responses during infection or after trauma (tissue injury).14  55 
CRP is produced in the liver and it is an acute phase reactant thus levels will rise when 56 
inflammation is present.15 Finally, Fibrinogen is a blood plasma protein that is made in the 57 
liver. It is also an acute phase reactant and levels rise when inflammation is present.16 58 
Unfavourable levels of these three inflammatory biomarkers have been found to be associated 59 
with several physical and mental health conditions.17-19   60 
Inflammatory processes have also been linked with muscle atrophy (and thus weaker grip 61 
strength),20 and muscle tissue expresses various transcriptional co-activators that may 62 
promote systemic anti-inflammatory effects.21 We have previously shown cross-sectional 63 
associations between systematic inflammation and muscle strength,22 consistent with others.23 64 
In another study, higher levels of IL-6 and CRP were associated with a two- to three-fold 65 
greater risk of losing more than 40% of grip strength over 3 years follow-up.24 The current 66 
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literature therefore suggests that inflammation is associated with muscle strength although the 67 
direction of the association is not clear.  68 
We hypothesized that inflammatory processes might in part explain the association between 69 
handgrip strength and mortality. The primary aim of the present study was to investigate the 70 
longitudinal association between handgrip strength and inflammatory markers, and examine 71 
the extent to which inflammatory markers explain the association between handgrip strength 72 
and mortality.  73 
METHODS 74 
Study sample and procedures 75 
The English Longitudinal Study of Ageing (ELSA) is a cohort study of older adults 76 
previously described.25 The sample was drawn from participants in the Health Survey for 77 
England (HSE), an annual cross-sectional survey that is designed to monitor the health of the 78 
general population. For wave 1, participants were recruited from the HSE in 1998, 1999 and 79 
2001. Eligibility criteria included, membership of a participating household from HSE in 80 
which at least one person had agreed to follow-up, born before 1 March 1952 and living in a 81 
private household in England at the time of the first wave of fieldwork. Data on grip strength 82 
and inflammatory markers was first collected at wave 2 (2004/5), and was thus used as the 83 
baseline for the present analyses. Inflammatory marker data collection were repeated at wave 84 
6 (2012/13) in survivors. Participants gave full informed consent to participate in the study. 85 
Ethical approval was obtained from the London Multi-center Research Ethics Committee, 86 
compliant with the Declaration of Helsinki.  87 
 88 
Clinical assessments 89 
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Anthropometric data (weight, waist, hip), grip strength and blood samples were collected by 90 
trained nurses. Participants were excluded from providing blood if they reported clotting and 91 
bleeding disorders, or taking anti-coagulant medication, and excluded from hand grip tests if 92 
they had swelling or inflammation, severe pain, or a recent injury or surgery to the hand in 93 
the preceding 6 months. Handgrip strength (kg) of the dominant hand was assessed using the 94 
Smedley hand-held dynamometer (Stoelting Co, IL, USA ), using the average of three 95 
measurements. Participants were required to hold the device at a right angle to their body and 96 
exert maximum force for a couple of seconds when instructed. Successive trials were 97 
alternated between dominant and non-dominant hands. Body weight was measured without 98 
shoes and in light clothing using Tanita electronic scales. Waist circumference was recorded 99 
twice midway between the iliac crest and lower rib and hip circumference around the widest 100 
portion of the buttocks using measuring tape. Central obesity was defined using waist to hip 101 
ratio (WHR) World Health Organization criteria (WHR≥0.85 in women and WHR≥0.90 in 102 
men). Blood samples were analyzed for high sensitivity C-reactive protein (CRP) and 103 
fibrinogen, described elsewhere.26 104 
 105 
Mortality  106 
The individual participant data were linked with death records from National Health Service 107 
registries for all consenting respondents (96.5% of the sample) up to February 2012. 108 
 109 
Covariates 110 
Trained interviewers asked questions on cigarette smoking (current, ex-smoker or non-111 
smoker), frequency of vigorous, moderate- and low-intensity physical activity (> once a 112 
week, once a week, 1 – 3 times a month, and hardly ever/never), chronic illnesses (at least 113 
one vs. none), and depressive symptoms (using a score >3 on the 8-item Centre of 114 
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Epidemiological Studies Depression scale).27 Wealth was self-reported, comprising of the 115 
total value of the participant’s home (excluding mortgage), financial assets such as savings, 116 
business assets, and physical wealth such as artwork or jewelry, which has been shown to 117 
best capture the material resources available to older adults.28 Wealth was grouped into 118 
quintiles relative to the ELSA sample. 119 
 120 
Statistical analysis 121 
Handgrip was standardised for body mass (as the two variables were moderately correlated, 122 
r>0.40) and treated as a continuous variable using the standardised score. Inflammatory 123 
markers were examined for normality and log transformed where appropriate.  In all analysis 124 
we ran models separately for men and women as handgrip strength was greater in men. We 125 
used general linear models to explore longitudinal associations between handgrip strength 126 
and change in inflammatory markers. Models were adjusted for age, sex, levels of 127 
inflammatory marker at baseline, wealth, physical activity, smoking, depressive symptoms, 128 
long standing illness, WHR. 129 
Cox proportional hazards regression models were employed to examine associations between 130 
grip strength and death. Years were the time scale for the follow-up calculated from age at 131 
death, and for participants with no record of an event, the data were censored at February 132 
2012. Plots of the Nelson-Aalen cumulative hazard estimates were examined to assess the 133 
proportional hazards assumption. We estimated models that initially contained the covariates 134 
age, sex, wealth (model 1), with further adjustment for physical activity, smoking, depressive 135 
symptoms, long standing illness, WHR (model 2).  These covariates were considered as 136 
confounders and selected a priori based on previous literature.29-31 We then added 137 
inflammatory markers (log CRP, fibrinogen) as continuous variables to theoretically test for 138 
mediation. In these mediation analyses we primarily focused on the change in effect estimate 139 
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and confidence intervals as “statistical significance” is less relevant.33 In sensitivity analyses 140 
we removed participants with activity limiting illnesses to examine if reverse causation was 141 
driving the results. All analyses were conducted using SPSS version 22 (SPSS, Chicago, IL). 142 
RESULTS 143 
At baseline 5,812 participants provided a blood sample and data on hand grip strength. After 144 
removing participants not consenting to mortality linkage (n=138) and those with missing 145 
covariates (n=434) the analytic sample for survival analyses comprised 5,240 participants 146 
(mean age 65.9 (SD 9.4) yrs; 53.8% female). In the longitudinal analyses that modelled 147 
change in inflammatory markers we further excluded participants that died through follow up 148 
(n=650) and those that did not provide blood samples at 8 years follow up (n=1,885), leaving 149 
an analytic sample of 2,705 participants (age 63.3±7.8 yrs; 55.2% female).  150 
At baseline the mean handgrip strength of dominant hand was 38.4±9.7 kg (men) and 151 
22.5±6.6 kg (women); normalised for body mass 0.47±0.12 (men) and 0.33±.10 (women). 152 
Participants in the highest hand grip strength tertiles were younger, more vigorously active, 153 
more affluent, reported less illness and depressive symptoms, and recorded lower prevalence 154 
of central obesity (Table 1). 155 
In longitudinal analyses that examined baseline grip strength and change in inflammatory 156 
markers over 8 years follow up inverse associations were evident with both fibrinogen and 157 
CRP in women only (Table 2). This was the case in fully adjusted analyses and also among 158 
the pooled sample of men and women. In men, the inverse associations between grip strength 159 
and change in inflammatory markers were evident in age adjusted models but did not persist 160 
in models adjusted for all covariates. 161 
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Over an average 9.7 ±1.4yrs follow up there were 650 deaths. There was an association 162 
between baseline grip strength and lower risk of mortality in women (hazard ratio [per SD 163 
increase in grip strength] = 0.85; 95% CI, 0.74, 0.98) after adjusting for age and wealth; no 164 
associations were seen in men (0.94; 0.83, 1.06) (Table 3). The association was somewhat 165 
attenuated after adjustment for clinical and behavioural risk factors, and further attenuated 166 
after adjusting for inflammatory markers. In mutually adjusted models the covariates 167 
associated with mortality included longstanding illness, physical inactivity, smoking, and 168 
CRP (Table S1, SDC, association between clinical and behavioural covariates with 169 
mortality). 170 
In sensitivity analyses we repeated the survival models after removal of participants who 171 
reported that their illness/disability limited their activity (n=1,409). The effect estimates 172 
remained largely unchanged albeit confidence intervals became wider as a result of reduced 173 
numbers (Table S2, SDC, the extent to which baseline clinical and biological factors explain 174 
associations between handgrip and mortality (excluding participants with activity limiting 175 
illnesses at baseline)). 176 
DISCUSSION 177 
In this population-based sample of older English adults, those with higher levels of grip 178 
strength were significantly more likely to have lower levels of systemic inflammatory 179 
markers, CRP and Fibrinogen, at follow-up. This association was seen in females, only. Grip 180 
strength was inversely associated with risk of mortality in females only. However, this 181 
association was attenuated to the null after adjustment for clinical and behavioural risk 182 
factors, and further attenuated after adjusting for inflammatory markers.  183 
Our findings support previous research on the association between grip strength and 184 
inflammatory markers34,35 and add to this body of work by showing that longitudinal 185 
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associations persist when controlling for a range of clinical and behavioural risk factors 186 
including measures of central adiposity.  187 
One plausible explanation for the association between grip strength and inflammation is that 188 
muscle mass is a predictor of greater grip strength and those who partake in regular exercise 189 
tend to have greater muscle mass. Exercise using large muscle groups produces a short-term, 190 
inflammatory response, and both cross-sectional comparisons and longitudinal exercise 191 
training studies demonstrate a long-term “anti-inflammatory” effect.36 Models in the present 192 
study controlled for levels of physical activity, though the types of activities (aerobics vs. 193 
resistance training) were not clearly separated. One other possible explanation is that high 194 
levels of circulating inflammatory markers and/or cytokines are associated with low muscle 195 
mass per se in older and obese people thus suggesting that muscle itself my play a role in 196 
regulating inflammatory markers.37-39  197 
It is feasible that inflammatory markers could be exercising their effect through a 198 
combination of lifestyle and behavioural factors; indeed adding inflammatory markers 199 
directly to Model 1, (Table 3) in women closely mimicked (HR=0.91; 95% CI, 0.79 - 1.05) 200 
the effect of adding  lifestyle / behavioural covariates. The association of grip strength with 201 
inflammation and mortality was more robust in females, which is consistent with other 202 
findings.22,40). Recent meta-analytic data showed grip strength was associated with reduced 203 
mortality in both genders, although the association was stronger in women.41 Our sex specific 204 
findings are unremarkable as the aging process particularly affects women, such that women 205 
are more susceptible to sarcopenia than men.42,43 In our own sample, the proportion of men 206 
having grip strength above the gender specific sarcopenia diagnosis cut-off is higher 207 
(90.5%>= 26kg) than that of women (84.8%>= 16kg).44 Furthermore, male and female 208 
hormones modulate the immune system differently, thus resulting in differential age-related 209 
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pathologies.45 Therefore, muscle strength might be particularly important for women in 210 
regulating chronic inflammation.46  211 
Clear strengths of the present study include the large population-based sample of older 212 
English adults, the longitudinal design, the objective measure of both the exposure and the 213 
outcome, and repeated measure of inflammatory biomarkers. However, the data must be 214 
interpreted considering the following limitations. Data on skeletal muscle mass were not 215 
available in the present cohort and we relied on measurements of muscle strength alone. 216 
While lean mass and strength (muscle quality) may not decline at the same rate, loss of lean 217 
mass is strongly associated with strength decline in both men and women.47 In our study, grip 218 
strength was standardized for body weight in the analyses. This approach allows us to 219 
account for muscle strength driven by body composition. There are ongoing discussions on 220 
how to standardize the procedure and utilization of grip strength measures in clinical and 221 
epidemiological studies, particularly in the ageing population.48 Although a unified method is 222 
yet to be developed, our approach of body weight standardized grip strength has shown to be 223 
a superior technique in the aging population.49,50 We were unable to account for underlying 224 
disease that were not detected through our measures; however, the results were largely 225 
unchanged after excluding participants with activity limiting illnesses suggesting reverse 226 
causation is an unlikely interpretation of our data. Participants retained in our analyses were 227 
generally healthier than the overall sample (driven by our exclusion criteria for blood and 228 
handgrip tests), thus our results are likely to reflect a conservative estimate of the true 229 
associations. Since the data are observational we cannot exclude the possibility of residual 230 
confounding. Nevertheless, recent evidence using Mendelian randomisation approaches 231 
suggested genetic correlations of grip strength with cardiometabolic traits and markers of 232 
frailty.51 Our study provides evidence on plausible biological pathways linking strength and 233 
mortality thus further strengthening causal inferences.  234 
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Perspective 235 
The present longitudinal analyses suggest that higher grip strength is associated with lower 236 
levels of inflammation at 8-year follow-up, and inflammatory markers partly explain the 237 
association between handgrip and mortality. Interventions designed to prevent a decline in 238 
physical functioning in females, especially, may improve inflammatory profiles and health. 239 
Such interventions may want to focus on functional task exercises as opposed to resistance 240 
exercises as functional task exercises have been shown to be more effective at improving 241 
functional task performance. Moreover, other literature suggests that functional task exercises 242 
may have an important role in helping maintain an independent lifestyle.52  243 
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Table 1. Baseline descriptive characteristics by sex specific handgrip tertiles. 409 
Baseline variable Sex specific handgrip tertileǂ 
Low  Middle High  
Age (yrs; mean, SD) 70.6 ± 10.3 65.8 ± 9.0 62.3 ± 7.8 
Smoking (%) 14.2 14.4 18.6 
Vigorous physical activity (%) 18.8 29.3 41.2 
Highest wealth quintile (%) 17.4 24.2 28.5 
Longstanding illness (%) 66.0 49.9 41.7 
Depressive symptoms (%) 18.8 11.9 10.2 
Central obesity (%) 68.0 56.9 23.7 
C-reactive protein (mg/L)† 2.8 (4.3) 2.0 (3.0) 1.3 (2.2) 
Fibrinogen (g/L)† 3.3 (0.9) 3.2 (0.9) 3.0 (0.8) 
ǂ grip strength standardised for body weight values; lowest tertile (<0.42 men, <0.28 women), 410 
middle (0.42 – 0.52 men, 0.28 – 0.37 women), highest (>0.52 men, >0.37 women). 411 
† data are median (interquartile range) 412 
 413 
 414 
 415 
 416 
 417 
 418 
 419 
 420 
 421 
 422 
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Table 2. Longitudinal association between grip strength and inflammatory markers over 8 years 423 
follow up: English Longitudinal Study Ageing 424 
 Log C-reactive protein 
 Model 1 Model 2 
Whole sample (n=2705) -0.060 (-0.092, -0.028) -0.049 (-0.083, -0.015) 
   
Men (n=1211) -0.046 (-0.087, -0.006) -0.038 (-0.082, 0.006) 
Women (n=1494) -0.068 (-0.11, -0.030) -0.055 (-0.095, -0.015) 
   
 Fibrinogen 
 Model 1 Model 2 
Whole sample (n=2624) -0.053 (-0.077, -0.029) -0.044 (-0.070, -0.019) 
   
Men (n=1168) -0.041 (-0.073, -0.009) -0.026 (-0.060, 0.008) 
Women (n=1456) -0.053 (-0.081, -0.025) -0.046 (-0.075, -0.016) 
B (95% CI) coefficients per SD increase in grip strength standardised for body weight 425 
Model 1 adjusted for age, sex and CRP or fibrinogen at baseline (sex adjustment excluded for sex 426 
specific models). 427 
Model 2 adjusted for age, sex, CRP or fibrinogen at baseline, waist-hip-ratio, smoking, physical 428 
activity, depressive symptoms, chronic illness, wealth. 429 
 430 
 431 
 432 
 433 
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Table 3. The extent to which baseline clinical and biological factors explain associations between 434 
handgrip and mortality 435 
 Model 1 
HR (95% CI) 
Model 2 
HR (95% CI) 
Model 3 
HR (95% CI) 
Whole sample 
(n=5240; 650 events ) 
0.87 (0.78, 0.97) 0.90 (0.80, 1.00) 0.93 (0.82, 1.04) 
    
Men  
(n=2422; 355 events) 
0.94 (0.83, 1.06) 0.93 (0.82, 1.06) 0.95 (0.84, 1.08) 
Women  
(n=2818; 295 events) 
0.85 (0.74, 0.98) 0.92 (0.79, 1.07) 0.95 (0.82, 1.11) 
 Hazard ratio, HR, (95% CI) for risk of mortality per SD increase in grip strength standardised for body 436 
weight. 437 
Model 1: adjusted for age, sex, wealth (sex adjustment excluded for sex specific models); 438 
Model 2: further adjusted for clinical and behavioural covariates; smoking, physical activity, chronic 439 
illness, central obesity, depressive symptoms 440 
Model 3: further adjusted for C-reactive protein, fibrinogen 441 
 442 
 443 
